A recent blog (“Payers and PBMs Profit from Obscure Pharmacy Fees, While Seniors See No Relief in Prescription Costs”) suggests performance-based price concessions are retained by PBMs, restrict the growth of independent pharmacies, and inflate Medicare Part D enrollee’s out-of-pocket costs—unfounded
The Value of PBMs PBMs are Committed to Helping Patients Pharmacy Benefit Companies (PBMs) are your advocates in the health care system, workingto lower prescription drug costs for patients and payers. PBMs administer prescription drug plans for more than 275
In case you missed it, Katie Payne, senior vice president for strategic communications for the Pharmaceutical Care Management Association (PCMA), discusses how the BIO International Convention happening this week in Boston, MA misses the critical opportunity to address the root
In case you missed it, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), discusses the root cause of high drug prices – big drug companies’ anti-competitive tactics used to keep more affordable prescription drugs from entering
(Washington, D.C.) — The Pharmaceutical Supply and Payment Chain Coalition issued the following statement in response to the Administration’s February 24, 2021, Executive Order on America’s Supply Chains. “As representative organizations of America’s pharmaceutical supply and payment chain, including prescription and over-the-counter
©2024 PCMA. All Rights Reserved.
